Federal Grant Opportunities

82,290 opportunities from Grants.gov – 1,023 currently open for applications. Data from SAM.gov and Grants.gov, covering federal grant programs and opportunities across all 50 states; see our methodology.

1,023 Open 81,267 Closed

All Opportunities

Page 24 of 1,646
Open National Institutes of Health

NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed)

Posted: Nov 6, 2024 Closes: Nov 12, 2027 CFDA 93.866
View →
Open National Institutes of Health

Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)

Posted: Nov 6, 2024 Closes: Jan 7, 2028 Up to $500K CFDA 93.394;93.395;93.396
View →
Open National Institutes of Health

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

Posted: Nov 6, 2024 Closes: Jan 7, 2028 Up to $500K CFDA 93.393;93.394;93.395
View →
Open National Institutes of Health

Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)

Posted: Nov 6, 2024 Closes: Jan 6, 2028 CFDA 93.839;93.847;93.866
View →
Open National Institutes of Health

Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)

Posted: Nov 6, 2024 Closes: Sep 7, 2026 Up to $499K CFDA 93.393;93.394;93.395;93.396
View →
Open National Institutes of Health

Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)

Posted: Nov 6, 2024 Closes: Jan 7, 2028 CFDA 93.865
View →
Open National Institutes of Health

Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)

Posted: Nov 6, 2024 Closes: Sep 7, 2026 CFDA 93.395
View →
Open National Institutes of Health

Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)

Posted: Nov 6, 2024 Closes: Jan 7, 2028 CFDA 93.393
View →
Open National Institutes of Health

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

Posted: Nov 6, 2024 Closes: Jan 7, 2027 Up to $500K CFDA 93.394;93.395
View →
Open National Institutes of Health

Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)

Posted: Nov 6, 2024 Closes: Sep 7, 2027 CFDA 93.286;93.394;93.395;93.866;93.867
View →
Open National Institutes of Health

Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)

Posted: Nov 6, 2024 Closes: Jan 7, 2027 CFDA 93.273;93.396
View →
Open National Institutes of Health

Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)

Posted: Nov 5, 2024 Closes: Oct 25, 2027 CFDA 93.399
View →
Open National Institutes of Health

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

Posted: Nov 5, 2024 Closes: Oct 25, 2027 CFDA 93.399
View →
Open National Institutes of Health

BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)

Posted: Nov 5, 2024 Closes: Sep 28, 2026 CFDA 93.173;93.213;93.242;93.273;93.279;93.286;93.853;93.865;93.866;93.867
View →
Open National Institutes of Health

BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)

Posted: Nov 5, 2024 Closes: Sep 28, 2026 CFDA 93.173;93.213;93.242;93.273;93.279;93.286;93.853;93.865;93.866;93.867
View →
Open National Institutes of Health

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)

Posted: Nov 4, 2024 Closes: Oct 20, 2027 CFDA 93.853
View →
Open National Institutes of Health

CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)

Posted: Nov 1, 2024 Closes: Oct 16, 2026 Up to $300K CFDA 93.853;93.855
View →
Open National Institutes of Health

Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)

Posted: Oct 31, 2024 Closes: Jan 7, 2028 CFDA 93.113;93.121;93.172;93.173;93.213;93.242;93.273;93.279;93.307;93.310;93.361;93.399;93.846;93.853;93.855;93.865;93.866;93.989
View →
Open National Institutes of Health

Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)

Posted: Oct 31, 2024 Closes: Jan 7, 2028 CFDA 93.242
View →
Open National Institutes of Health

Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)

Posted: Oct 31, 2024 Closes: Jan 7, 2028 CFDA 93.242
View →
Open National Institutes of Health

Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)

Posted: Oct 31, 2024 Closes: Jun 2, 2027 CFDA 93.121;93.213;93.313;93.393;93.866
View →
Open National Institutes of Health

Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)

Posted: Oct 31, 2024 Closes: Jun 2, 2027 CFDA 93.121;93.213;93.313;93.393;93.866
View →
Open National Institutes of Health

Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)

Posted: Oct 30, 2024 Closes: Jan 27, 2027 Up to $500K CFDA 93.121;93.213;93.242;93.273;93.279;93.310;93.846;93.853;93.859;93.866;93.867
View →
Open National Institutes of Health

Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)

Posted: Oct 30, 2024 Closes: Jan 7, 2028 CFDA 93.113;93.121;93.172;93.242;93.273;93.279;93.310;93.399;93.853;93.865;93.866;93.989
View →
Open National Institutes of Health

Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)

Posted: Oct 30, 2024 Closes: Jan 7, 2028 CFDA 93.121;93.351;93.865
View →
Open National Institutes of Health

Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)

Posted: Oct 29, 2024 Closes: Apr 15, 2027 Up to $250K CFDA 93.879
View →
Open National Institutes of Health

Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)

Posted: Oct 29, 2024 Closes: Jan 7, 2028 CFDA 93.113;93.121;93.172;93.213;93.233;93.242;93.273;93.279;93.307;93.310;93.361;93.399;93.837;93.838;93.839;93.840;93.846;93.847;93.853;93.855;93.865;93.866;93.867
View →
Open National Institutes of Health

Translational Neural Devices (R61/R33 - Clinical Trial Optional)

Posted: Oct 29, 2024 Closes: Jan 28, 2027 CFDA 93.853
View →
Open National Institutes of Health

Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 - Clinical Trials Required)

Posted: Oct 28, 2024 Closes: Nov 5, 2027 CFDA 93.853
View →
Open National Institutes of Health

Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)

Posted: Oct 28, 2024 Closes: Jan 7, 2028 CFDA 93.853;93.866
View →
Open National Institutes of Health

Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)

Posted: Oct 28, 2024 Closes: Nov 16, 2027 Up to $100K CFDA 93.121;93.173;93.242;93.350;93.853;93.855
View →
Open National Institutes of Health

BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional)

Posted: Oct 23, 2024 Closes: Jun 15, 2027 CFDA 93.173;93.213;93.242;93.273;93.286;93.853;93.865;93.866;93.867
View →
Open National Institutes of Health

NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

Posted: Oct 23, 2024 Closes: Jan 6, 2028 CFDA 93.121
View →
Open National Institutes of Health

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)

Posted: Oct 22, 2024 Closes: Oct 20, 2027 Up to $750K CFDA 93.853
View →
Open National Institutes of Health

Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)

Posted: Oct 22, 2024 Closes: Oct 20, 2027 Up to $750K CFDA 93.853
View →
Open National Institutes of Health

NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)

Posted: Oct 18, 2024 Closes: Oct 15, 2027 CFDA 93.173
View →
Open National Institutes of Health

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)

Posted: Oct 15, 2024 Closes: Oct 14, 2026 Up to $250K CFDA 93.394
View →
Open National Institutes of Health

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Posted: Oct 15, 2024 Closes: Oct 14, 2026 CFDA 93.394
View →
Open National Institutes of Health

Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)

Posted: Oct 15, 2024 Closes: Dec 3, 2026 CFDA 93.113;93.121;93.172;93.173;93.233;93.242;93.279;93.313;93.398;93.837;93.838;93.839;93.840;93.853;93.866;93.867;93.989
View →
Open National Institutes of Health

Emerging Global Leader Award (K43 Independent Clinical Trial Required)

Posted: Oct 15, 2024 Closes: Dec 3, 2026 CFDA 93.113;93.172;93.173;93.233;93.242;93.279;93.313;93.398;93.837;93.838;93.839;93.840;93.853;93.866;93.989
View →
Open National Institutes of Health

Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)

Posted: Oct 10, 2024 Closes: Oct 14, 2026 CFDA 93.394
View →
Open National Institutes of Health

Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)

Posted: Oct 10, 2024 Closes: Jan 7, 2027 CFDA 93.121;93.307;93.313;93.399
View →
Open National Institutes of Health

Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required)

Posted: Oct 10, 2024 Closes: Jan 6, 2028 CFDA 93.121
View →
Open DOC NOAA - ERA Production

FY 2024 – 2026 Broad Agency Announcement (BAA), Office of Oceanic and Atmospheric Research (OAR)

Posted: Oct 9, 2024 Closes: Sep 30, 2026 CFDA 11.015
View →
Open U.S. National Science Foundation

Cultural Anthropology Program Senior Research Awards

Posted: Oct 8, 2024 Closes: Aug 17, 2026 CFDA 47.075
View →
Open Centers for Disease Control and Prevention - ERA

Occupational Safety and Health Education and Research Centers (T42)

Posted: Oct 7, 2024 Closes: Oct 26, 2028 Up to $9.0M CFDA 93.262
View →
Open National Institutes of Health

Limited Competition: CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed)

Posted: Oct 4, 2024 Closes: Jan 7, 2028 CFDA 93.846;93.855
View →
Closed U.S. National Science Foundation

Earth Sciences Postdoctoral Fellowships

Posted: Oct 3, 2024 CFDA 47.050
View →
Open National Institutes of Health

Research Experiences and/or Mentoring Networks through Research Education to Enhance Clinician-Scientists' Participation in NIDCDs Research (R25 Clinical Trial Not Allowed)

Posted: Oct 2, 2024 Closes: Sep 29, 2027 Up to $250K CFDA 93.173
View →
Open Advanced Research Projects Agency Energy

SEEDING CRITICAL ADVANCES FOR LEADING ENERGY TECHNOLOGIES WITH UNTAPPED POTENTIAL (SCALEUP) READY

Posted: Oct 2, 2024 Closes: Sep 29, 2029 Up to $20.0M CFDA 81.135
View →

Looking for something specific?

Use the search bar above or browse grant programs by category or agency.